JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.720
+0.240 (9.68%)
May 7, 2026, 4:08 PM HKT

HKG:2126 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1031,0185189081,7415,333
Market Cap Growth
83.95%96.55%-42.92%-47.87%-67.36%-47.83%
Enterprise Value
836717-7-461012,831
Last Close Price
2.722.511.282.264.3513.44
PS Ratio
3.503.233.084.7410.57141.07
PB Ratio
1.781.650.420.490.651.56
P/TBV Ratio
2.722.510.830.851.052.20
EV/Sales Ratio
2.652.27--0.6174.89
Debt / Equity Ratio
0.470.470.360.190.120.05
Net Debt / Equity Ratio
-0.43-0.43-0.29-0.41-0.47-0.60
Net Debt / EBITDA Ratio
1.331.330.871.411.762.29
Net Debt / FCF Ratio
3.083.081.001.691.812.66
Asset Turnover
0.210.210.080.070.050.01
Inventory Turnover
2.372.372.452.292.431.35
Quick Ratio
1.281.281.663.854.579.31
Current Ratio
1.451.451.744.044.789.53
Return on Equity (ROE)
-64.37%-64.37%-41.40%-38.04%-32.89%-22.58%
Return on Assets (ROA)
-11.43%-11.43%-14.99%-14.43%-14.75%-13.99%
Return on Capital Employed (ROCE)
-41.20%-41.20%-37.80%-30.30%-28.10%-26.40%
Earnings Yield
-56.01%-60.69%-121.33%-93.23%-54.95%-16.17%
FCF Yield
-7.89%-8.55%-69.57%-49.87%-39.85%-14.60%
Buyback Yield / Dilution
-0.52%-0.52%-0.51%-0.35%-2.59%-203.07%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.